AVBP - ArriVent BioPharma, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$46.00
DETAILS
HIGH:
$47.00
LOW:
$45.00
MEDIAN:
$46.00
CONSENSUS:
$46.00
UPSIDE:
57.97%
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | ||||||||||||||||||
| R&D Expenses | 42.3 | 37.6 | 32.2 | 32.2 | 27.7 | 61.3 | 20.2 | 20.1 | 21.8 | 17.0 | 20.0 | 14.3 | 20.4 | 10.2 | 8.6 | 10.1 | 5.8 | 5.8 |
| SG&A Expenses | 10.4 | 8.5 | 6.6 | 6.1 | 5.9 | 5.5 | 3.5 | 4.1 | 3.9 | 3.7 | 3.1 | 2.4 | 2.2 | 1.9 | 1.8 | 1.7 | 1.5 | 1.5 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 52.7 | 46.1 | 38.8 | 38.3 | 33.6 | 66.8 | 23.7 | 24.2 | 25.7 | 20.7 | 23.1 | 16.7 | 22.6 | 12.2 | 10.4 | 11.8 | 7.3 | 7.3 |
| Operating Income | ||||||||||||||||||
| Operating Income | (52.7) | (46.1) | (38.8) | (38.3) | (33.6) | (66.8) | (23.7) | (24.2) | (25.7) | (20.7) | (23.1) | (16.7) | (22.6) | (12.2) | (10.4) | (11.8) | (7.3) | (7.3) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 2.8 | 2.8 | 3.3 | 3.3 | 2.2 | 2.4 | 3.1 | 3.7 | 3.8 | 3.3 | 1.9 | 2.3 | 1.0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | ||||||||||||||||||
| EBITDA | (49.9) | (43.3) | (35.5) | (35.0) | (31.4) | (64.4) | (20.6) | (20.6) | (21.9) | (17.4) | (21.2) | (14.4) | (21.6) | 0 | 0 | 0 | 0 | 0 |
| EBIT | (49.9) | (43.3) | (35.5) | (35.0) | (31.4) | (64.4) | (20.6) | (20.6) | (21.9) | (17.4) | (21.2) | (14.4) | (21.6) | (12.2) | (10.4) | (11.8) | (7.3) | (7.3) |
| Income Before Tax | (49.9) | (43.3) | (35.5) | (35.0) | (31.4) | (64.4) | (20.6) | (20.6) | (21.9) | (17.4) | (21.2) | (14.4) | (21.6) | (12.2) | (10.4) | (11.8) | (7.3) | (7.3) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (49.9) | (43.3) | (35.5) | (35.0) | (31.4) | (64.4) | (20.6) | (20.6) | (21.9) | (17.4) | (21.2) | (14.4) | (21.6) | (12.2) | (10.4) | (11.8) | (7.3) | (7.3) |
| Per Share Data | ||||||||||||||||||
| EPS (Basic) | -1.05 | -0.96 | -0.84 | -0.83 | -0.90 | -1.90 | -0.61 | -0.61 | -0.65 | -0.52 | -0.63 | -0.43 | -0.64 | -0.36 | -0.31 | -0.35 | -5.76 | -5.76 |
| EPS (Diluted) | -1.05 | -0.96 | -0.84 | -0.83 | -0.90 | -1.90 | -0.61 | -0.61 | -0.65 | -0.52 | -0.63 | -0.43 | -0.64 | -0.36 | -0.31 | -0.35 | -5.76 | -5.76 |
| Shares Outstanding | 47.6 | 45.1 | 38.5 | 41.9 | 35.0 | 33.9 | 33.6 | 33.6 | 33.5 | 33.5 | 33.5 | 33.5 | 33.5 | 33.5 | 33.5 | 33.5 | 1.3 | 1.3 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||
| Cash & Cash Equivalents | 154.7 | 62.1 | 45.5 | 112.7 | 112.8 | 49.9 | 74.3 | 282.9 | 298.7 | 317.4 | 150.4 | 141.4 | 157.8 | 0 | 163.4 | 0 |
| Short-Term Investments | 218.4 | 264.3 | 267.3 | 187.6 | 122.9 | 126.2 | 144.6 | 0 | 0 | 0 | 0 | 25 | 25 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0.1 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.8 | 0.9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 21.1 | 20.9 | 19.8 | 19.9 | 13.2 | 8.0 | 7.4 | 8.6 | 8.3 | 8.2 | 9.2 | 13.3 | 15.4 | (163.4) | 18.9 | (37.3) |
| Total Current Assets | 394.2 | 348.7 | 332.9 | 321.2 | 250.1 | 185.8 | 227.0 | 292.4 | 308.5 | 327.5 | 160.0 | 180.0 | 198.7 | 0 | 182.6 | 0 |
| Non-Current Assets | ||||||||||||||||
| Property, Plant & Equipment | 0.4 | 0.4 | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.3 | 0.0 | 0.1 | 0 | 0.1 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 5.1 | 18.8 | 29.4 | 47.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.2 | 0.2 | 0.3 | 0.2 | 0.5 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 2.8 | 2.0 | 0.1 | 0 | 0.1 | 0 |
| Total Non-Current Assets | 0.5 | 0.6 | 0.3 | 5.3 | 19.4 | 29.7 | 48.0 | 0.3 | 0.3 | 0.4 | 3.1 | 2.0 | 0.2 | 0 | 0.2 | 0 |
| Total Assets | 394.7 | 349.3 | 333.2 | 326.6 | 269.5 | 215.5 | 274.9 | 292.7 | 308.9 | 327.8 | 163.1 | 182.0 | 198.8 | 0 | 182.8 | 0 |
| Current Liabilities | ||||||||||||||||
| Account Payables | 2.2 | 8.7 | 5.9 | 5.9 | 4.1 | 4.4 | 3.8 | 4.6 | 3.8 | 4.1 | 4.5 | 4.8 | 6.5 | 0 | 3.1 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 25.3 | 1.9 | 6.5 | 4.4 | 2.8 | 1.5 | 4.2 | (0.1) | 2.0 | 1.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 27.8 | 25.0 | 25.9 | 21.6 | 19.6 | 13.0 | 17.3 | 15.2 | 12.1 | 10.0 | 11.6 | 10.1 | 12.8 | 0 | 8.4 | 0 |
| Non-Current Liabilities | ||||||||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (41.2) |
| Total Non-Current Liabilities | 0.0 | 0.3 | 0 | 0 | 0 | 0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0 | 0 | 0 | 0.0 | (41.2) |
| Total Liabilities | 27.9 | 25.3 | 25.9 | 21.6 | 19.6 | 13.0 | 17.3 | 15.2 | 12.2 | 10.1 | 11.8 | 10.1 | 12.8 | (174.5) | 8.4 | (41.2) |
| Stockholders' Equity | ||||||||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0 | 0 |
| Retained Earnings | (497.9) | (448.0) | (404.6) | (369.1) | (334.1) | (302.7) | (238.3) | (217.7) | (197.1) | (175.3) | (157.8) | (136.7) | (122.3) | 0 | (88.5) | 0 |
| Accumulated Other Comprehensive Income | (0.3) | (0.3) | 0.0 | 0.2 | (0.0) | (0.0) | (0.2) | 0 | 0 | 0 | 0 | (0.1) | 0 | 0 | 0 | (48.6) |
| Total Stockholders' Equity | 366.8 | 324.0 | 307.2 | 305.0 | 249.9 | 202.5 | 257.7 | 277.5 | 296.7 | 317.7 | 151.3 | 171.9 | 186.0 | 174.5 | 174.5 | 41.2 |
| Total Liabilities & Equity | 394.7 | 349.3 | 333.2 | 326.6 | 269.5 | 215.5 | 274.9 | 292.7 | 308.9 | 327.8 | 163.1 | 182.0 | 198.8 | 0 | 182.8 | 0 |
| Debt Metrics | ||||||||||||||||
| Total Debt | 0.4 | 0.4 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.2 | 0.3 | 0.3 | 0.0 | 0.1 | 0 | 0.1 | 0 |
| Net Debt | (154.3) | (61.7) | (45.5) | (112.6) | (112.7) | (49.7) | (74.1) | (282.5) | (298.4) | (317.1) | (150.1) | (141.3) | (157.8) | 0 | (163.2) | 0 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||
| Net Income | (49.9) | (43.3) | (35.5) | (35.0) | (31.4) | (64.4) | (20.6) | (20.6) | (21.9) | (17.4) | (21.2) | (14.4) | (21.6) | (12.2) | (10.4) | (11.8) | (7.3) | (7.3) |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 6.7 | 5.5 | 3.2 | 3.7 | 3.3 | 2.3 | 1.0 | 0.9 | 0.8 | 0.6 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Change in Working Capital | 11.6 | (3.5) | 4.7 | (4.5) | 2.0 | (5.9) | 3.5 | 3.4 | 2.0 | (1.8) | 6.0 | (1.3) | 12.8 | (4.9) | (5.6) | 1.7 | (2.0) | (2.0) |
| Other Non-Cash Items | (7.9) | (0.6) | (3.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.3 |
| Operating Cash Flow | (39.6) | (41.9) | (30.7) | (35.8) | (26.1) | (68.0) | (16.2) | (16.3) | (19.1) | (18.6) | (14.9) | (15.4) | (8.6) | (16.9) | (15.9) | (9.9) | (8.9) | (8.9) |
| Investing Activities | ||||||||||||||||||
| Capital Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (14.0) | (64.4) | (151.2) | (90.4) | (21.6) | (9.8) | (194.2) | 0 | 0 | 0 | 0 | 0 | (25) | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 60.1 | 68.0 | 80.0 | 39.6 | 35.5 | 46.6 | 0 | 0 | 0 | 0 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 1.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 46.1 | 3.6 | (71.2) | (50.8) | 13.9 | 36.8 | (192.5) | 0 | 0 | 0 | 25 | 0 | (25) | 0 | 0 | 0 | 0 | 0 |
| Financing Activities | ||||||||||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | (0.1) | 0 | (0.2) | 0 | 0 | 0 | 0.0 | 0.0 | 0 | (1.0) | 0 | 0.0 | 0.0 | 0 | 30.0 | 30.0 |
| Financing Cash Flow | 86.1 | 54.9 | 34.7 | 86.5 | 75.1 | 6.8 | 0.1 | 0.5 | 0.4 | 185.6 | (1.1) | (1.0) | (0.0) | 45.0 | 109.7 | 0 | 30.0 | 30.0 |
| Cash Position | ||||||||||||||||||
| Net Change in Cash | 92.6 | 16.6 | (67.1) | (0.1) | 62.9 | (24.4) | (208.6) | (15.8) | (18.7) | 167.0 | 9.0 | (16.5) | (33.6) | 28.1 | 93.8 | (9.9) | 79.5 | 0 |
| Cash at Beginning | 62.1 | 45.5 | 112.7 | 112.8 | 49.9 | 74.3 | 282.9 | 298.7 | 317.4 | 150.4 | 141.4 | 157.8 | 191.5 | 163.4 | 69.5 | 79.5 | 0 | 0 |
| Cash at End | 154.7 | 62.1 | 45.5 | 112.7 | 112.8 | 49.9 | 74.3 | 282.9 | 298.7 | 317.4 | 150.4 | 141.4 | 157.8 | 191.5 | 163.4 | 69.5 | 79.5 | 0 |
| Free Cash Flow | (39.6) | (41.9) | (30.7) | (35.8) | (26.1) | (68.0) | (16.2) | (16.3) | (19.1) | (18.6) | (14.9) | (15.4) | (8.6) | (16.9) | (15.9) | (9.9) | (8.9) | (8.9) |
| Key Metrics | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | (52.7) | (46.1) | (38.8) | (38.3) | (33.6) | (66.8) | (23.7) | (24.2) | (25.7) | (20.7) | (23.1) | (16.7) | (22.6) | (12.2) | (10.4) | (11.8) | (7.3) | (7.3) |
| Net Income | (49.9) | (43.3) | (35.5) | (35.0) | (31.4) | (64.4) | (20.6) | (20.6) | (21.9) | (17.4) | (21.2) | (14.4) | (21.6) | (12.2) | (10.4) | (11.8) | (7.3) | (7.3) |
| EPS (Diluted) | -1.05 | -0.96 | -0.84 | -0.83 | -0.90 | -1.90 | -0.61 | -0.61 | -0.65 | -0.52 | -0.63 | -0.43 | -0.64 | -0.36 | -0.31 | -0.35 | -5.76 | -5.76 |
| Balance Sheet | ||||||||||||||||||
| Cash & Equivalents | 154.7 | 62.1 | 45.5 | 112.7 | 112.8 | 49.9 | 74.3 | 282.9 | 298.7 | 317.4 | 150.4 | 141.4 | 157.8 | 0 | 163.4 | 0 | ||
| Total Assets | 394.7 | 349.3 | 333.2 | 326.6 | 269.5 | 215.5 | 274.9 | 292.7 | 308.9 | 327.8 | 163.1 | 182.0 | 198.8 | 0 | 182.8 | 0 | ||
| Total Debt | 0.4 | 0.4 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.2 | 0.3 | 0.3 | 0.0 | 0.1 | 0 | 0.1 | 0 | ||
| Stockholders' Equity | 366.8 | 324.0 | 307.2 | 305.0 | 249.9 | 202.5 | 257.7 | 277.5 | 296.7 | 317.7 | 151.3 | 171.9 | 186.0 | 174.5 | 174.5 | 41.2 | ||
| Cash Flow | ||||||||||||||||||
| Operating Cash Flow | (39.6) | (41.9) | (30.7) | (35.8) | (26.1) | (68.0) | (16.2) | (16.3) | (19.1) | (18.6) | (14.9) | (15.4) | (8.6) | (16.9) | (15.9) | (9.9) | (8.9) | (8.9) |
| Capital Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | (39.6) | (41.9) | (30.7) | (35.8) | (26.1) | (68.0) | (16.2) | (16.3) | (19.1) | (18.6) | (14.9) | (15.4) | (8.6) | (16.9) | (15.9) | (9.9) | (8.9) | (8.9) |